- Home
- EVH vs ELVN Comparison
EVH vs ELVN Comparison
Compare EVH & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVH
- ELVN
- Stock Information
- Founded
- EVH 2011
- ELVN 2016
- Country
- EVH United States
- ELVN United States
- Employees
- EVH N/A
- ELVN N/A
- Industry
- EVH Other Consumer Services
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- EVH Consumer Discretionary
- ELVN Health Care
- Exchange
- EVH Nasdaq
- ELVN Nasdaq
- Market Cap
- EVH 1.1B
- ELVN 1.2B
- IPO Year
- EVH 2015
- ELVN 2020
- Fundamental
- Price
- EVH $9.02
- ELVN $17.69
- Analyst Decision
- EVH Strong Buy
- ELVN Strong Buy
- Analyst Count
- EVH 14
- ELVN 5
- Target Price
- EVH $16.93
- ELVN $41.20
- AVG Volume (30 Days)
- EVH 2.4M
- ELVN 371.3K
- Earning Date
- EVH 08-07-2025
- ELVN 08-19-2025
- Dividend Yield
- EVH N/A
- ELVN N/A
- EPS Growth
- EVH N/A
- ELVN N/A
- EPS
- EVH N/A
- ELVN N/A
- Revenue
- EVH $2,195,920,000.00
- ELVN N/A
- Revenue This Year
- EVH N/A
- ELVN N/A
- Revenue Next Year
- EVH $15.79
- ELVN N/A
- P/E Ratio
- EVH N/A
- ELVN N/A
- Revenue Growth
- EVH N/A
- ELVN N/A
- 52 Week Low
- EVH $7.06
- ELVN $13.30
- 52 Week High
- EVH $33.63
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- EVH 38.96
- ELVN 34.68
- Support Level
- EVH $9.14
- ELVN $18.18
- Resistance Level
- EVH $9.72
- ELVN $20.26
- Average True Range (ATR)
- EVH 0.53
- ELVN 1.14
- MACD
- EVH -0.11
- ELVN -0.38
- Stochastic Oscillator
- EVH 36.12
- ELVN 4.86
About EVH Evolent Health Inc
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.